5'-酸结合循环二核酸,Endo-S-CDN,表现出令人印象深刻的抗瘤活动在活体中,当用皮下剂量
Simpa K Yeboah1, Sagarika Meher2, Haley Anne Harper3
1James Tarpo Jr. and Margaret Tarpo Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, United States.
ACS bio & med chem Au
|August 27, 2025
概括
新的内分泌S-CDN,强烈的STING激动剂,在癌症免疫治疗中显示出有效的皮下输送. 这些循环二核酸对具有挑战性的瘤模型提供了强大的保护,改善了瘤内剂量限制.
科学领域:
- 免疫学
- 药理学
- 癌症学
背景情况:
- 循环二核酸 (CDN) 激活了在癌症免疫治疗中流行的cGAS-STING通路.
- 现有的CDN类型需要瘤内注射,这限制了难以达到的瘤的临床应用.
研究的目的:
- 评估新型S-CDN作为STING激动剂的体内疗效.
- 进行结构-活动关系研究以优化endo-S-CDN的发展.
- 评估内分泌S-CDN的潜力.
主要方法:
- 结尾-S-CDN类型的结构-活动关系分析.
- 在MC38和B16- F10瘤模型中进行了体内疗效研究.
- 在皮下注射S-CDN.
主要成果:
- 鉴定出具有强大的S-CDN与STING激动剂活性.
- 在体内通过皮下注射显示强大的抗瘤保护.
- 对MC38和B16- F10瘤模型的有效性得到证实.
结论:
- 固体S-CDN是有效的STING激动剂,适用于皮下输送.
- 通过皮下注射,End-S-CDN具有显著的抗瘤功效.
- 这些发现支持endo-S-CDN作为一种方便的癌症免疫治疗的临床潜力.
更多相关视频
08:46Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides
Published on: July 26, 2018
8.8K
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11.1K
相关概念视频
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Phosphodiester Linkages
102.9K
Overview
Phosphodiester bond forms when a phosphoric acid molecule (H3PO4) links with two hydroxyl groups (–OH) of two other molecules, forming two ester bonds. Two water molecules are released in this process. The phosphodiester bond is commonly found in nucleic acids (DNA and RNA) and plays a critical role in their structure and function.
Phosphodiester Bonds Link Nucleotides Together
DNA and RNA are polynucleotides or long chains of nucleotides that are linked together. A nucleotide is...
Phosphodiester bond forms when a phosphoric acid molecule (H3PO4) links with two hydroxyl groups (–OH) of two other molecules, forming two ester bonds. Two water molecules are released in this process. The phosphodiester bond is commonly found in nucleic acids (DNA and RNA) and plays a critical role in their structure and function.
Phosphodiester Bonds Link Nucleotides Together
DNA and RNA are polynucleotides or long chains of nucleotides that are linked together. A nucleotide is...
102.9K
